Bruker's Mass Spec Demo facility: Ensuring safe operation in COVID-19 and beyondVideo
This video showcases Bruker's Mass Spec Demo facility and how they are keeping employees safe and in operation during COVID-19 and beyond.
Cubis® II Modular Precision-, Analytical- and MicrobalancesVideo
For scientists in R&D and analytical laboratories needing the most reliable lab weighing results, the Cubis® II from Sartorius is a completely configurable, high performance portfolio of balance hardware and software that will align with your unique demands and compliance requirements to maximize operational efficiency and experimental outcomes.
Learn about how Personalized Medicine is changing how drugs are being developed and how healthcare is being delivered, and how Horizon is helping to enable this change.Watch Now
Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.Watch Now
In this webinar, Dr Robert Williams, Chief Development Scientist, Cancer Research UK, will discuss how partnership between academia and industry can accelerate drug development.Watch Now
Guangwen Chen, Professor, Dalian Institute Of Chemical Physics, speaking at Flow Chemistry Congress.Watch Now
High Content Biology & Cardiac Regeneration: Proliferation and Multi-lineage Differentiation Screens using Cardiac Progenitor CellsVideo
Lauren Drowley, Associate Principal Scientist, AstraZeneca, speaking at Stem Cells in Drug Discovery.Watch Now
Andras Guttman, Adjunct Professor, Northeastern University, speaking at Flow Chemistry Congress.Watch Now
I will discuss hurdles for the development of therapies for muscle disorders. I will present our platforms based upon iPS cells, inducible myogenesis and human artificial chromosomes. Extension of these technologies for tissue engineering and drug development will also be discussed.Watch Now
Flow Reactors with Polymeric Membranes for Catalytic Aerobic Partial Oxidation Chemistry in Pharmaceuticals and Specialty ChemicalsVideo
Thatcher Root, Professor of Chemical and Biological Engineering, University of Wisconsin, speaking at Flow Chemistry Congress.Watch Now
Davide Danovi, Director, Kings College London, speaking at Stem Cells in Drug Discovery.Watch Now